Mercer Global Advisors
ASBP

Mercer Global Advisors’s Aspire Biopharma ASBP Stock Holding History

Mercer Global Advisors’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16 Buy
+3
New +$31 ﹤0.01% 6045

Other funds holding ASBP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CA
Crewe Advisors Salt Lake City, Utah $1.38B AUM 41.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.73B AUM 42.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Mercer Global Advisors's ASBP Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Aspire Biopharma (ASBP) in Q2 2026: 3 shares worth $16. The stake represents ﹤0.01% of the portfolio and ranks #6045 among its holdings.

7 funds tracked by Wall St. Rank hold ASBP as of Q2 2026.

  • Mercer Global Advisors held 3 shares of Aspire Biopharma worth $16 as of Q2 2026.
  • Aspire Biopharma was a new Mercer Global Advisors position in Q2 2026.
  • Aspire Biopharma made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #6045 holding.
  • 7 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.